Current Ratio of Vir Biotechnology, Inc. from 30 Jun 2020 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Vir Biotechnology, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2020 to 31 Dec 2025.
- Vir Biotechnology, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 6.65x, a 37% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Vir Biotechnology, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 6.65x | -3.9x | -37% | 31 Dec 2025 |
| Q3 2025 | 7.45x | -3.02x | -29% | 30 Sep 2025 |
| Q2 2025 | 7.84x | -3.04x | -28% | 30 Jun 2025 |
| Q1 2025 | 8.98x | -0.89x | -9% | 31 Mar 2025 |
| Q4 2024 | 10.55x | +3.26x | +45% | 31 Dec 2024 |
| Q3 2024 | 10.46x | +4.27x | +69% | 30 Sep 2024 |
| Q2 2024 | 10.88x | +4.84x | +80% | 30 Jun 2024 |
| Q1 2024 | 9.87x | +4.5x | +84% | 31 Mar 2024 |
| Q4 2023 | 7.29x | +2.39x | +49% | 31 Dec 2023 |
| Q3 2023 | 6.2x | +1.37x | +28% | 30 Sep 2023 |
| Q2 2023 | 6.04x | +1.77x | +42% | 30 Jun 2023 |
| Q1 2023 | 5.37x | +1.12x | +26% | 31 Mar 2023 |
| Q4 2022 | 4.9x | +0.75x | +18% | 31 Dec 2022 |
| Q3 2022 | 4.83x | +0.43x | +9.8% | 30 Sep 2022 |
| Q2 2022 | 4.26x | -0.83x | -16% | 30 Jun 2022 |
| Q1 2022 | 4.26x | -1.14x | -21% | 31 Mar 2022 |
| Q4 2021 | 4.14x | -4.83x | -54% | 31 Dec 2021 |
| Q3 2021 | 4.4x | -4.53x | -51% | 30 Sep 2021 |
| Q2 2021 | 5.09x | -2.81x | -36% | 30 Jun 2021 |
| Q1 2021 | 5.39x | 31 Mar 2021 | ||
| Q4 2020 | 8.97x | 31 Dec 2020 | ||
| Q3 2020 | 8.92x | 30 Sep 2020 | ||
| Q2 2020 | 7.9x | 30 Jun 2020 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.